Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Esomeprazole/sodium bicarbonate - Chong Kun Dang

Next Previous
Drug Profile

Esomeprazole/sodium bicarbonate - Chong Kun Dang

Alternative Names: (s)-omeprazole/sodium bicarbonate; EsoDuo; Esomeprazole magnesiun trihydrate/sodium bicarbonate; s-omeprazole magnesium trihydrate/sodium bicarbonate; s-omeprazole/sodium bicarbonate; Sodium bicarbonate/(s)-omeprazole; Sodium bicarbonate/esomeprazole

Latest Information Update: 06 May 2019

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Chong Kun Dang
  • Class 2 pyridinylmethylsulfinylbenzimidazoles; Alkalinising agents; Antibacterials; Antiulcers; Gastric antisecretories; Small molecules; Sodium compounds
  • Mechanism of Action Antacids; Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Gastro-oesophageal reflux

Most Recent Events

  • 03 May 2019 Chemical structure information added
  • 30 Apr 2019 Launched for Gastro-oesophageal reflux in South Korea (PO)- First global launch
  • 29 Jan 2019 Chong Kun Dang initiates enrolment in a phase IV trial for Gastro-oesophageal reflux in South Korea (NCT03928470)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top